Inside Innovation

After accepting the Nobel Prize award in chemistry, David Baker is eager to return to his lab at the University of Washington to continue paving

Scott Lesley, the president and chief scientific officer of InduPro, reflects on his decision to leave Merck & Co. to lead the Seattle-based startup and

The Health Sciences and Services Authority of Spokane County (HSSA) has awarded matching grants for bioscience-based economic development to three Spokane-based companies, one Seattle-based company

Seattle-based InBios International, a biotech focused on the development of diagnostic tests for infectious diseases, received a $16.5 million award from the Biomedical Advanced Research

Intrinsic Medicine, a Seattle-based biotech, is developing human milk oligosaccharide (HMO) drugs to treat a range of gut immune microbiota brain axis disorders, with its

LSW members RareCyte and Alpenglow Biosciences were ranked among the top 10 spatial biology companies of 2024. In June, RareCyte completed a $20 million financing

Dr. Ingrid Swanson Pultz, a trailblazer in protein design, began her career at the University of Washington with a passion for creating innovative biological solutions.

Healionics, a medical technology company headquartered in Seattle, announced that its STARgraft arteriovenous (AV) graft for dialysis access has received Breakthrough Device designation from the

Derrick Hicks, Ph.D., a researcher in the Baker lab at the University of Washington’s Institute for Protein Design (IPD), has received a $387,050 grant by

Tune Therapeutics, a Seattle-based biotech company, is developing a groundbreaking approach to cure hepatitis B (HBV) by deactivating viral genes without damaging human DNA. The

Three Fred Hutch Cancer Center researchers have received over $4 million in grants from the Washington Research Foundation to advance immunotherapies for Merkel cell carcinoma,